Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate

As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those of monthly risedronate (RIS). We enrolled 30 cases of osteoporosis (OP; 16 in the MIN group [mean...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Osteoporos Sarcopenia
Main Authors: Kamimura, Mikio, Nakamura, Yukio, Ikegami, Shota, Komatsu, Masatoshi, Uchiyama, Shigeharu, Kato, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Osteoporosis 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372746/
https://ncbi.nlm.nih.gov/pubmed/30775483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2016.07.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados